Neuroimmunology

Clinical and Basic Immunodermatology

Volumn , Issue , 2008, Pages 31-44

  Lee, Erica ^a   Granstein, Richard D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84890132770     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84800-165-7_3     Document Type: Chapter

References (96)

1. Lewis T. Local Means of Producing the Triple Response in the Blood Vessels of Human Skin and Their Responses. London: Shaw&Son, 1927: 46-64
2. Steinhoff M, Stander S, Seeliger S, et al. Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 2003;139:1479-1488
3. Bayliss W. On the origin from the spinal cord of vasodilator fibers of the hind limb, and on the nature of these fibers. J Physiol 1901;26:173-209
4. Bruce AN. Vasodilator axon reflexes. Q J Exp Physiol 1913;6:339-354
5. Freedberg IM, Eisen AZ, Wolff K, et al. Fitzpatrick's Dermatology in General Medicine, 6th ed. New York: McGraw-Hill. 2003
6. Metze D, Luger T. Nervous system in the skin: New basic science in dermatology. In: Freinkel RK, Woodley DT, eds. The Biology of the Skin. New York: Parthenon, 2001:153-165
7. Stander S, Steinhoff M, Schmelz M, et al. Neurophysiology of pruritus. Arch Dermatol 2003; 139: 1463-1470
8. Sternini C. Organization of the peripheral nervous system: Autonomic and sensory ganglia. J Invest Dermatol Symp Proc 1997;2:1-7
9. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev 2000;21:457-487
10. Scholzen T, Armstrong CA, Bunnett NW, et al. Neuropeptides in the skin: Interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998;7:81
11. Lotti T, Hautmann G, Panconesi E, Neuropeptides in skin. J Am Acad Dermatol 1995;33:482-96
12. Zegarska B, Leinska A, Tyrakowski T. Clinical and experimental aspects of cutaneous neurogenic inflammation. Pharmacol Rep 2006;58:13-21
13. Eedy DJ, Shaw C, Johnston CF, Buchanan KD. The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol 1994;19:761-763
14. Ansel JC, Armstrong CA, Song I, et al. Interactions of the skin and nervous system. J Invest Dermatol Symp Proc 1997;2:23-26
15. Scholzen TE, Steinhoff M, Bonaccorshi P et al. Neutral endopeptidase terminates substance Pinduced inflammation in allergic contact dermatitis. J Immunol 2001;166:1285-1291
16. Misery L. The neuro-immuno-cutaneous system and ultraviolet radiation. Photodermatol Photoimmunol Photomed 2000;16:78-81
17. Brain SD, Cox HM. Neuropeptides and their receptors: Innovative science providing novel therapeutic targets. Br J Pharmacol 2006;147:S202-S211
18. Torii H, Yan Z, Hosoi J, Granstein RD. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: Further support for a functional relationship between Langerhans cells and epidermal nerves. J Invest Dermatol 1997;109:586-91
19. Scholzen TE, Brzoska T, Kalden DH, et al. Effect of ultraviolet light on the release of neuropeptides and neuroendocrine hormones in the skin: Mediators of photodermatitis and cutaneous inflammation. J Invest Dermatol Symp Proc 1999;4:55-60
20. Koizumi H, Tanaka H, Fukaya T, Ohkawara A. Substance P induces intracellular calcium increase and translocation of protein kinase C in epidermis. Br J Dermatol 1992;127;595-9
21. Rossi R, Johansson O. Cutaneous innervation and the role of neuronal peptides in cutaneous inflammation: A minireview. Eur J Dermatol 1998;8:299-306
22. Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002;97-103
23. Luger TA. Neuromediators-A crucial component of the skin immune system. J Dermatol Sci 2002;30:87-93
24. Kodali S, Ding W, Huang J, et al. Vasoactive intestinal peptide modulates langerhans cell immune function. J Immunol 2004;173:6082-6088
25. Steinhoff M, McGregor GP, Radleff-Schlimme A, et al. Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: Expression of PACAP-38 is increased in patients with psoriasis. Regul Pept 1999;80:49-55
26. Kodali S, Friedman I, Ding W, et al. Pituitary adenylate cyclase-Activating polypeptide inhibits cutaneous immune function. Eur J Immunol 2003;33:3070-3079
27. Amara SG, Jonas V, Rosenfeld MG, et al. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982;298:240-4
28. Hosoi J, Murphy GF, Egan CL et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993;363:159-63
29. Nong YH, Titus RG, Ribeiro JM, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989;143:45-49
30. Fox FE, Kubin M, Cassin M, et al. Calcitonin generelated peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: Effects on B7, interleukin 10, and interleukin 12. J Invest Dermatol 1997;108:43-8
31. Carucci JA, Ignatius R, Wei Y, et al. Calcitonin generelated peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven t cell-proliferative responses via the type I calcitonin gene-related peptide receptor. J Immunol 2000;164:3494-3499
32. Gillardon F, Moll I, Michel S, et al. Calcitonin generelated peptide and nitric oxide are involved in ultraviolet radiation-induced immunosuppression. Eur J Pharmacol 1995;293:395-400
33. Niizeki H, Alard P, Streilein JW. Calcitonin generelated peptide is necessary for ultraviolet B-impaired induction of contact hypersensitivity. J Immunol 1997;159:5183-5186
34. Garssen J, Buckley TL, Van Loveren H. A role for neuropeptides in UVB-induced systemic immunosuppression. Photochem Photobiol 1998;68:205-10
35. Bohm, M, Luger TA, Tobin DJ, Garcia-Borron J. Melanocortin receptor ligands: New horizons for skin biology and clinical dermatology. J Invest Dermatol 2006;126:1966-1975
36. Brazzini B, Ghersetich I, Hercogova J, Lotti T. The neuro-immuno- cutaneous endocrine network: Relationship between mind and skin. Dermatol Ther 2003;16:123-131
37. Catania A, Airaghi L, Garofalo L, et al. The neuropeptide alpha-MSH in HIV infection and other disorders in humans. Ann NY Acad Sci 1998;840:848-56
38. Grabbe S, Bhardwaj RS, Mahnke K, et al. Alphamelanocyte stimulating hormone induces hapten-specific tolerance in mice. J Immunol 1996;156:473-478
39. Catania A, Cutuli M, Garofalo L, et al. The neuropeptide ?-MSH in host defense. Ann NY Acad Sci 2000;917:227-231
40. Ceriani G, Diaz J, Murphree S, et al. The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1994;1:28-32
41. Chiao H, Foster S, Thomas R, et al. Alpha-melanocyte stimulation hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996;97:2038-2044
42. Schallreuter KU, Lemke KR, Pittelkow MR, et al. Catecholamines in human keratinocyte differentiation. J Invest Dermatol 1995;104:953-957
43. Seiffert K, Hosoi J, Torri, H, et al. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 2002;168:6128:6135
44. Maestroni GJM. Dendritic cells migration controlled by ?1b-Adrenergic receptors. J Immunol 2000;165:6743-6747
45. Lambert RW, Campton K, Ding W, et al. Langerhans cell expression of neuropeptide Y and peptide YY. Neuropeptides 2002;36:246-251
46. Holzer AM, Granstein RD. Role of extracellular adenosine triphosphate in human skin. J Cutan Med Surg 2004;90-96
47. Cook SP, McCleskey EW. Cell damage excites nociceptors through release of cytosolic ATP. Pain 2002;95:41-47
48. Seiffert K, Ding W, Wagner JA, Granstein RD. ATP?S enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 2006;126:1017-1027
49. Granstein RD, Ding W, Huang J et al. Augmentation of cutaneous immune responses by ATP gamma S: Purinergic agonists define a novel class of immunologic adjuvants. J Immunol 2005;174:7725-31
50. Roosterman D, Goerge T, Schneider SW, et al. Neuronal control of skin function: The skin as a neuroimmunoendocrine organ. Physiol Rev 2006;86:1309-1379
51. Borici-mazi, Kouridakis S, Kontou-Fili K. Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: The effect of cetirizine and dimethindene. Allergy 1999;54:46-56
52. Akiyama M, Watanabe Y, Nishikawa T. Immunohistochemical characterization of human cutaneous mast cells in urticaria pigmentosa (cutaneous mastocytosis). Acta Pathol Jpn 1991;41: 344-9
53. Artuc M, Bohm M, Grutzhau A, et al. Human mast cells in the neurohormonal network: Expression of POMC, detection of precursor proteases and evidence for IgE-dependent secretion of alpha-MSH. J Invest Dermatol 2006;126:1976-81
54. Twycross R, Greaves MW, Handwerker H, et al. Itch: More than scratching the surface. Q J Med 2003;96:7-26
55. Sonkoly E, Muller A, Lauerma A. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006;117:411-7
56. Raap U, Kapp A. Neuroimmunological findings in allergic skin diseases. Curr Opin Allergy Clin Immunology 2005;5:419-424
57. Sugiura H, Omoto M, Hirota Y, et al. Density and fine structure of peripheral nerves in various skin lesions of atopic dermatitis. Arch Dermatol Res 1997;289:125-131
58. Pincelli C, Sevignani C, Manfredini R, et al. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol 1994;103:13-18
59. Staniek V, Liebich C, Vocks E, et al. Modulation of cutaneous Sp receptors in atopic dermatitis after UVA irradiation. Acta Derm Venereol 1998'78:92-94
60. Wallengren J, Sundler F. Phototherapy reduces the number of epidermal and CGRP-positive dermal nerve fibers. Acta Derm Venereol 2004;84: 111-115
61. Ostlere LS, Cowen T, Rustin MH. Neuropeptides in the skin of patients with atopic dermatitis. Clin Exp Dermatol 1995;6:462-7
62. Fantini F, Pincelli C, Romualdi P, et al. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1992;3:127-8
63. Jarvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003;295:2-7
64. Anand A, Springall DR, Blank MA, et al. Neuropeptides in skin disease: Increased VIP in eczema and psoriasis but not axillary hyperhidrosis. Br J Dermatol 1991;124:547-549
65. Saraceno R, Kleyn CE, Terenghi G, Griffiths CEM. The role of neuropeptides in psoriasis. Br J Dermatol 2006;154:876-882
66. Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: An immunocytochemical and radioimmunoassay study. J Invest Dermatol 1991;96:434-438
67. Chan J, Smoller BR, Raychauduri SP, et al. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 1997;289:611-616
68. Glinska W, Brodecka H, Glinska-Ferenz M, Kowalski D. Increased concentration of beta-endorphin in sera of patients with psoriasis and other inflammatory dermatoses. Br J Dermatol 1994;131:260-4
69. Al'Abadie MS, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol 1994;131:160-5
70. Falaballa R, Barona MI, Echeverri IC, Alzate A. Substance P may play a part during depigmentation in vitiligo. A pilot study. J Eur Acad Dermatol Venereol 2003;17:355-6
71. Lazarova R, Hristakieva E, Lazarov N, Shani J. Vitiligo-related neuropeptides in nerve fibers of the skin. Arch Physiol Biochem 2000;108:262-267
72. Liu PY, Bondesson L, Lontz W, Johansson O. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: A case-control study. Arch Dermatol Res 1996;288:67-675
73. Gulec AT, Tanriverdi N, Duru C et al. The role of psychological factors in alopecia areata and the impact of the disease on the quality of life. Int J Dermatol 2004;43:352-356
74. Kim HS, Cho DH, Kim HJ, et al. Immunoreactivity of corticotropin- releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata. Exp Dermatol 2006;15:515-22
75. Gutwald J, Goebeler M, Sorg C. Neuropeptides enhance irritant and allergic contact dermatitis. J Invest Dermatol 1991;96:695-698
76. Asahina A, Hosoi J, Beissert S, et al. Inhibition of the induction of delayed-Type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995;154:3056
77. Goebeler M, Henseleit U, Roth J, Sorg C. Substance P and calcitonin gene-related peptide modulate leukocyte infiltration to mouse skin during allergic contact dermatitis. Arch Dermatol Res 1994;286:341-346
78. Torii H, Hosoi J, Beissert S, et al. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin generelated peptide. J Leukoc Biol 1997;61:216-223
79. Hart PH, Townley SL, Grimbaldeston MA, et al. Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression. Methods 2002;28:79-89
80. Townley SL, Grimbaldeston MA et al. Nerve growth factor, neuropeptides and mast cells in ultraviolet-B-induced systemic suppression of contact hypersensitivity responses in mice. J Invest Dermatol 2002;396-401
81. Noonan FP, De Fabo ED. Immunosuppression by ultraviolet B radiation: Initiation by urocanic acid. Immunol Today 1992;13:250-254
82. Khalil Z, Townley SL, Grimbaldeston MA, et al. Cis-urocanic acid stimulates neuropeptide release from peripheral sensory nerves. J Invest Dermatol 2001;117:886-891
83. Haegerstrand A, Dalsgaard CJ, Jonzon B, et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990;87:3299-303
84. Olerud JE, Usui ML, Seckin D et al. Neutral endopeptidase expression and distribution in human skin and wounds. J Invest Dermatol 1999;112:873-81
85. Antezana M, Sullivan S, Usui M, et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol 2002;119:1400-4
86. Peters EM, Ericson ME, Hosoi J, et al. Neuropeptide control mechanisms in cutaneous biology: Physiological and clinical significance. J Invest Dermatol 2006;126:1937-1947
87. Tobin DJ, Kauser S. Hair melanocytes as neuroendocrine sensors-pigments of our imagination. Mol Cell Endocrinol 2005;243:1-11
88. Kauser S, Thody AJ, Schallreuter KU, et al. A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes. Endocrinology 2005;146:532-43
89. Lavker RM, Kligman AM. Chronic heliodermatitis: A morphologic evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J Invest Dermatol 1998;90:325-30
90. Toyoda M, Hara M, Bhawan J. Epidermal innervation correlates with severity of photodamage: A quantitative ultrastructural study. Exp Dermatol 1996;5:260-6
91. Toyoda M, Nakamura M, Nakada K, et al. Characteristic alterations of cutaneous neurogenic factors in photaged skin. Br J Dermatol 2005;153:13-22
92. Eves PC, MacNeil S, Haycock JW. α-Melanocyte stimulating hormone, inflammation and human melanoma. Peptides 2006;27:444-452
93. Kim MH, Cho D, Kim HJ, et al. Investigation of the corticotropin- releasing hormone-proopiomelanocortin axis in various skin tumors. Br J Dermatol 2006;155:910-915
94. Kennedy C, ter Huurne J, Berkhout M, et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001;117: 294-300
95. Bastiaens MT, ter Huurne JA, Kielich C, et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001;68:884-94
96. Kanetsky PA, Rebbeck TR, Hummer AJ, et al. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 2006;66:9330-7